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Introduction
Since the discovery of Sry (Gubbay et al., 1990), many
transcription factors have been characterised and included in
the Sox family (Sry-related HMG box), based on their
homology to the HMG DNA-binding domain. These proteins
are involved in a number of developmental processes, making
the Sox family one of the most prolific of its kind with more
than 30 vertebrate members recognised to date. Through the
phylogenetic analysis of the HMG box, Sox family members
have been classified into 11 groups (Bowles et al., 2000).
Together with Sox6 and Sox13, Sox5 belongs to group D.
SoxD genes contain more exons than do other Sox genes
(Schepers et al., 2002). Additional complexity is introduced
through tightly regulated mRNA processing, the functional
significance of alternative splicing being highlighted by the
differential expression of the distinct isoforms. Indeed, a short
variant of Sox5 (SSox5) is found only in adult testis, while
longer isoforms (LSox5) are expressed in other tissues during
mammalian development (Denny et al., 1992; Lefebvre et al.,
1998; Hiraoka et al., 1998). LSox5 variants share common
structural features with other group D members, including a
leucine zipper and glutamine-rich regions thought to be
involved in dimerisation (Hiraoka et al., 1998; Lefebvre et al.,
1998). In the mouse, LSox5/Sox6 heterodimers cooperate with
Sox9 to activate the Col2a1 gene, which encodes type II
collagen, an extracellular matrix component that is essential for
chondrogenesis (Lefebvre et al., 1998). Indeed, it is in this
process that LSox5 has been most thoroughly studied.
Mutations in SOX9 produce campomelic dysplasia, a syndrome
that is often associated with autosomal XY sex reversal and
involves the severe malformation of most cartilage-derived
structures (Meyer et al., 1997). Furthermore, mouse chimeras
containing Sox9–/– embryonic stem cells inactivate early
cartilage markers, including the Col2a1 gene (Bi et al., 1999),
a phenomenon that is also observed in Sox5, Sox6 double
mutant embryos (Smits et al., 2001). This scheme is further
clarified by the severe downregulation of LSox5 and Sox6
expression produced after Sox9 inactivation using the
Cre/LoxP system in chondrogenic cell lineages, thus
demonstrating that LSox5 and Sox6 are genetically downstream
of Sox9 in chondrocytes (Akiyama et al., 2002). Interestingly,
in the chick, Sox9 has been implicated in the differentiation of
the neural crest (Cheung and Briscoe, 2002) and here we
characterise chick LSox5 and show its participation in cranial
neural crest development.
The neural crest is a cell population that originates at the
boundary between the neural plate and the prospective
epidermis. Once specified, the cells of the neural crest
delaminate from the neural folds/neural tube by undergoing a
process of epithelium to mesenchyme transition (EMT). These
cells then migrate along characteristic pathways and
differentiate into a wide variety of derivatives upon reaching
Members of the Sox family of transcription factors are
involved in a number of crucial developmental processes,
including sex determination, neurogenesis and skeletal
development. LSox5 is a member of the group D Sox factors
that, in conjunction with Sox6 and Sox9, promotes
chondrogenesis by activating the expression of cartilage-
specific extracellular matrix molecules. We have cloned the
chicken homologue of LSox5 and found that it is initially
expressed in the premigratory and migratory neural crest
after Slug and FoxD3. Subsequently, the expression of LSox5
is maintained in cephalic crest derivatives, and it appears to
be required for the development of the glial lineage, the
Schwann cells and satellite glia in cranial ganglia.
Misexpression of LSox5 in the cephalic neural tube
activated RhoB expression throughout the dorsoventral
axis. Furthermore, the prolonged forced expression of
LSox5 enlarged the dorsal territory in which the neural
crest is generated, extended the ‘temporal window’ of
neural crest segregation, and led to an overproduction of
neural crest cells in cephalic regions. In addition to HNK-
1, the additional neural crest cells expressed putative
upstream markers (Slug, FoxD3) indicating that a
regulatory feedback mechanism may operate during
neural crest generation. Thus, our data show that in
addition to the SoxE genes (Sox9 and Sox10) a SoxD gene
(Sox5) also participates in neural crest development and
that a cooperative interaction may operate during neural
crest generation, as seen during the formation of cartilage.
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their destination, including neurons and glia of the peripheral
nervous system, pigment cells, craniofacial cartilage and bone
(LeDouarin and Kalcheim, 1999). Diffusible factors of the
BMP, BMP antagonists, FGF and WNT families, together with
retinoic acid, seem to direct the first steps of neural crest
induction (Liem et al., 1995; Selleck et al., 1998; Garcia-Castro
et al., 2002; Villanueva et al., 2002), although different
transcription factors are thought to interpret these extracellular
signals. Indeed, the winged-helix family member FoxD3 and
Sox9 have been implicated in the induction of the neural crest
(Kos et al., 2001; Dottori et al., 2001; Cheung and Briscoe,
2003); and members of the Snail family of transcription
factors, Snail and Slug, are required to trigger the EMT
(reviewed in Nieto, 2002). The neural crest derivatives become
committed at different stages of their development and some
transcription factors seem to direct this lineage commitment.
At low concentrations, Sox10 apparently maintains the
multipotency of the crest cells and at higher doses it inhibits
neuronal differentiation, favouring the generation of peripheral
glia and melanoblasts (Kim et al., 2003; Paratore et al., 2001).
by contrast, FoxD3 represses melanogenesis (Kos et al., 2001;
Dottori et al., 2001) and it has been demonstrated that Sox9 is
necessary for the determination of the chondrogenic lineage in
cranial neural crest cells (Mori-Akiyama et al., 2003).
We have characterised chick LSox5, which shows a high
degree of similarity to its mammalian counterpart and an
identical HMG box. Two splice variants were found that contain
specific structural motifs susceptible to post-translational
modification. We show that LSox5 is expressed in premigratory
cranial neural crest cells and that following delamination,
LSox5 expression coincides with a characteristic pattern of crest
migration. High expression levels are maintained in the crest-
derived components of cranial glia, including Schwann cells
and satellite glia. Misexpression of LSox5 in the midbrain and
the hindbrain provoked the rapid, cell autonomous upregulation
of RhoB. This misexpression of LSox5 also led to an extension
of the dorsal territory and of the developmental window in
which the neural crest is produced, and augmented the
generation of cephalic neural crest. The less immediate effects
of LSox5 include the upregulation of other neural crest markers,
such as Slug, FoxD3 and Sox10. Thus, we propose that LSox5
participates in the generation of the cranial neural crest and in
the subsequent differentiation of the cranial glia lineage.
Materials and methods
Embryos
Fertilised chicken eggs were purchased from Granja Santa Isabel
(Córdoba, Spain). Eggs were incubated, opened and staged according
to Hamburger and Hamilton (Hamburger and Hamilton, 1951).
Cloning and sequencing of chicken LSox5
Chicken LSox5 was isolated in a subtractive screen to isolate genes
involved in the early stages of brain development. A cDNA
subtraction library was generated with the ‘Clontech PCR select-
cDNA subtraction kit’ (Clontech, catalog number K1804-1), using the
anterior region of stage 8 and stage 11 chick embryos as the ‘driver’
and ‘tester’ populations, respectively. One of the clones isolated in the
screen was a partial cDNA for LSox5, and the full-length cDNAs of
LSox5-I and LSox5-II (2.3 and 2.4 kb, respectively) were obtained by
PCR walking using a stage14 lambda zap cDNA library. The
nucleotide sequence of LSox5 appears in the EMBL, GenBank and
DDBJ Nucleotide Sequence Databases under the Accession Numbers
AJ626988 and AJ626989. A putative short isoform (SSox5) results
from the deletion of the first 1248 coding nucleotides of LSox5-II.
Hence, we analysed the expression of the alternatively spliced LSox5
isoforms by RT-PCR using the flanking oligonucleotides: sense 5 ¢ -
CTCCCAGCCTTTCACCTTCCC-3 ¢ ; and antisense 5 ¢ -GCTTTCT-
GGAGTCCCTTTTAT-3¢ .
In ovo electroporation
Full-length LSox5-II (772 amino acids) and SSox5 (356 amino acids)
cDNAs were cloned into a pCX vector (Niwa et al., 1991) to be used
in electroporation assays. Each plasmid (4 mg/ml) was injected
between the neural folds of stage 8 chicken embryos together with
pCX-EGFP (0.5 mg/ml), and the embryos were immediately
electroporated as described previously (Itasaki et al., 1999) with some
modifications. Electroporation was performed with a TSS20 Intracel
square pulse generator, programmed to deliver five 50 mseconds, 15
V pulses at 4 Hz, through custom-made platinum electrodes. The eggs
were sealed and allowed to develop for another 6-7, 12 or 20-24 hours,
at which point the embryos were removed and processed for in situ
hybridisation or immunohistochemistry. Control electroporation
assays were performed by injecting pCX-EGFP (4.5 mg/ml) alone.
Whole mount in-situ hybridisation
Single or double whole-mount in situ hybridisation was carried out as
described (Nieto et al., 1996). For double hybridisation, one probe
was labelled with digoxigenin-UTP and the second with fluorescein-
UTP. The probes were detected with anti-digoxigenin or anti-
fluorescein antibodies coupled to alkaline phosphatase, and visualised
with NBT-BCIP (digoxigenin) or INT-BCIP (fluorescein; all reagents
and antibodies supplied by Roche). The LSox5 probes were prepared
from the full-length LSox5-II cDNA isoform. The fluorescein-labelled
LSox5 probe was often used to control for electroporation without
masking the blue staining of the probe under analysis. Embryos were
then photographed prior to embedding in gelatin or agarose for
vibratome sectioning.
Anti-LSox5 generation and immunohistochemistry
The LSox5-II cDNA was cloned into the pRSET plasmid (Invitrogen),
from which a fusion protein was generated to immunise rabbits and
obtain antisera. Protein extracts from embryonic fibroblasts stably
infected with RCAS vectors expressing LSox5-I or LSox5-II were
analysed by western blotting to test the affinity and specificity of the
sera. One serum, 32A-III, specifically recognised LSox5 in western
blots and produced a pattern of immunostaining comparable with that
obtained by in situ hybridisation (not shown). This serum was used
throughout this work. For immunohystochemistry, 10 m m cryostat or
40 m m vibratome agarose sections were permeabilised with 0.5% Triton
X-100 (USB), blocked with 10% FBS and incubated overnight at 4°C
with the primary antibody. After washing, the cryostat sections were
incubated for 1 hour with secondary antibodies or overnight in the case
of agarose vibratome sections. The primary antibodies were used at the
following concentrations: LSox5, 1:4000; EGFP, 1:1000 (Molecular
Probes); Laminin 1, 1:1000 (Sigma); Pax7, 1:1000 (DSHB) (Ericson et
al., 1996); Slug, 1:1000 (62.1E6, DSHB) (Liem et al., 1995); P0, 1:1000
(1E8, DSHB) (Bhattacharyya et al., 1991); HNK-1, 1:4000 (prepared
from a cell line obtained from ATCC); Islet-1/2, 1:1000 (40.2D6,
DSHB) (Ericson et al., 1992). Cy2- or Cy3-conjugated secondary
antibodies were used (Jackson; 1:1000 dilution). HNK-1 whole-mount
immunohistochemistry was performed as described (Nieto et al., 1996).
Results
Two isoforms of the transcription factor LSox5
expressed in chick embryos
In an attempt to isolate genes involved in the early stages of
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chick brain development, we have identified clones
corresponding to chick LSox5 in a subtractive screen where
cDNAs from stage 8 chick embryos were compared with those
isolated from stage 11. cDNA clones that showed a strong
similarity to mammalian LSox5 and that were more intensely
expressed at stage 11 were identified. Then, a full-length cDNA
was generated by PCR cDNA walking, which rendered two
distinct isoforms. The longer LSox5-II differed from the shorter
LSox5-I sequence because of a 105 bp insertion that encoded
additional amino acids at position 56 (the amino acid 
sequence of chicken LSox5 and its alignment with 
the human orthologue is shown in Fig. S1 
at http://dev.biologists.org/cgi/content/full/131/18/4455/DC1).
By comparing the LSox5 cDNA sequence with public database
entries, we mapped the chicken Sox5 gene to chromosome 1
and established an exon/intron organisation very similar to that
described for its mammalian orthologues (Ikeda et al., 
2002) (the location and sequence of exon/
intron boundaries is shown in Table S1 at
http://dev.biologists.org/cgi/content/full/131/18/4455/DC1).
The two cDNA isoforms isolated in the chick encode
proteins of 737 and 772 amino acids, predicted to be of 80.99
and 84.95 kDa, respectively. The amino acid sequences are
highly similar to their mammalian counterparts, LSox5-II
sharing 95.7% and 93% of its residues with its human and
mouse orthologues, respectively. The HMG box is identical in
all three species, but out of this region, the chick LSox5-II
contains 113 serine/threonine residues, 10% more than its
mammalian orthologues. Strikingly, the majority of the
additional S/T residues are concentrated between amino acids
426-456, and within this region, four serines and one threonine
are concentrated in a short nine amino acid stretch. In silico
screening of EST databases, together with the analysis of the
corresponding genomic entries has shown that the inclusion of
this serine-rich domain (SRD) varies across species. It is
constitutively incorporated in zebrafish and fugu LSox5
polypeptides, absent in human, mouse and rat, and it may be
alternatively spliced in the chicken (see Fig. S2 
at http://dev.biologists.org/cgi/content/full/131/18/4455/DC1
shows the DNA sequence at the intron-exon boundary of
different species, providing a molecular basis for this
diversity). These phylogenetic variations may reflect the
evolution of mechanisms that regulate LSox5 activity which
involve differential phosphorylation.
We analysed the expression of the two distinct LSox5 isoforms
by RT-PCR on cDNA samples from stages 9-23, with a pair of
primers flanking the inserted domain. Two bands corresponding
in size to that predicted for each isoform were detected at all
stages and at the same intensity. Furthermore, in western blots of
whole embryo protein extracts, a serum generated against LSox5
also detected two bands of similar intensity and with apparent
molecular masses slightly higher than those predicted from the
primary structure (the expression of LSox5 as obtained by both
RT-PCR and western blot is shown in Fig. S1 at http://
dev.biologists.org/cgi/content/full/131/18/4455/DC1). Thus, we
detected LSox5 in embryos at all the stages examined and no
differences in expression could be detected between the two
isoforms during development, either by RT-PCR or
immunoblotting. Nevertheless, as these studies were performed
on whole embryos, we cannot exclude the possibility that local
differences do indeed exist.
LSox5 is expressed in premigratory and migratory
cephalic neural crest cells
The long splice variants derived from the Sox5 gene were first
identified in the mouse. They have been shown to play a crucial
role in chondrogenesis (Lefebvre et al., 1998) and to be
expressed in the developing pancreas, as well as in a variety of
adult human tissues (Ikeda et al., 2002; Lioubinski et al., 2003).
At early stages of chick development, LSox5 mRNA appeared
to be distributed in the neural crest and its derivatives (Fig. 1).
The expression of LSox5 was first detected at stage 7 in the
neural folds (Fig. 1A), closely following the onset of the
expression of other neural crest markers such as Slug (data not
shown) and FoxD3 (Kos et al., 2001). At all the stages
analysed, LSox5 was also expressed at high levels in the
notochord (Fig. 1C).
Within the neural plate, the expression of LSox5 was
dependent on its anteroposterior location, as transcripts were
found both dorsally and ventrally at prosencephalic levels
(Fig. 1B), whereas at more caudal levels they were restricted
to the most dorsal region where the neural crest forms (Fig.
1C). As the neural folds extended caudally, so did the dorsal
restriction of LSox5 expression. At stages 8 and 9, LSox5
continued to be expressed in the anterior prosencephalon,
although this region does not produce neural crest (Fig. 1D,F)
and nor were neural crest markers such as Slug and FoxD3
expressed here (Fig. 1E) (Kos et al., 2001). At later stages,
LSox5-expressing cells became migratory (Fig. 1G) and were
found among the population of mesencephalic and
rhombencephalic migratory crest cells (Fig. 1I). LSox5
expression then progressively diminished in the dorsal
cephalic neural tube caudal to the forebrain, coincident with
its apparition in cells that were migrating along well-defined
neural crest pathways (Anderson and Meier, 1981; Tosney,
1982; Lumsden et al., 1991).
To confirm whether the migratory cells that express LSox5
were neural crest cells, we examined the expression of Slug, a
marker of the premigratory and the migratory neural crest
population (Fig. 1J) (Nieto et al., 1994; del Barrio and Nieto,
2004). Within the neural tube, all cells that expressed LSox5
also expressed Slug (Fig. 1J-L), confirming that LSox5 is
expressed in premigratory neural crest cells. Nevertheless, a
subpopulation of cells only expressed Slug, indicating that
LSox5 is not common to all premigratory crest cells. In the
early stages of migration, many cells expressed both these
proteins, although as migration proceeded, LSox5 expression
augmented while the expression of Slug diminished (del Barrio
and Nieto, 2004). The onset of Slug expression prior to that of
LSox5 indicated that Slug precedes LSox5 in the genetic
cascade at play during neural crest development.
LSox5 expression is maintained in the glial lineage
of the cephalic peripheral nervous system
We then compared the expression of LSox5 with that of other
neural crest markers and its distribution in neural crest
derivatives. RhoB is a small GTPase implicated in the
delamination of the neural crest that lies downstream of Slug
(Liu and Jessell, 1998; del Barrio and Nieto, 2002). RhoB
mRNA is expressed in a small population of premigratory
neural crest cells and in the early migratory cells. Its expression
pattern is very similar to that of LSox5 in the premigatory
neural crest cells, suggesting that at a particular stage of
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development they may be co-expressed in neural crest cells.
The glycoprotein epitope HNK1 (Tucker et al., 1984) is found
in the majority of migratory neural crest cells (Le Dourain and
Kalcheim, 1999; del Barrio and Nieto, 2004). Although most
migratory neural crest cells were labelled for both HNK1 and
LSox5 (Fig. 1M), an early migratory cell population contained
LSox5 alone.
In the head, all the peripheral glia and most neurons in both
the sensory and autonomic ganglia are lineages derived from
the neural crest (reviewed by LeDourain and Kalcheim, 1999).
The population of peripheral glia includes satellite glia of the
cranial ganglia and the Schwann cells associated with the
cranial nerves. Our immunohistochemical analysis revealed
that LSox5 expression was maintained in both these glial cell
types. In Schwann cell precursors that ensheath the cranial
nerves, LSox5 is co-expressed with P0, an early marker of both
myelinating and nonmyelinating cells (Bhattacharyya et al.,
1991) (Fig. 1N). In the cranial ganglia, anti-LSox5 labelled
small rod-shaped nuclei whose morphology indicated that they
might correspond to satellite glia. This population of LSox5-
positive cells was clearly different from the neuroblasts that
express Lim-domain factors of the Islet class (Fedtsova et al.,
2003) (Fig. 1O).
LSox5 misexpression in the cephalic neural tube
augments the production of neural crest
To investigate whether LSox5 plays a role in the migration
and/or differentiation of the neural crest, we ectopically
induced expression of the longest LSox5-II isoform on the
right-hand side of the neural tube. This was achieved by
electroporating pCX-LSox5 (together with pCX-EGFP as a
marker of transformation) into the cephalic region of stage 8
embryos. After 20-24 hours, uniform EGFP labelling was
detected on one side of the neural tube and in the characteristic
streams of migratory cranial neural crest (Fig. 2A). A similar
distribution of ectopic LSox5 was observed by
immunohistochemistry (Fig. 2B,C). Under these conditions,
the expression of HNK1 increased on the electroporated side,
particularly in the post-otic regions, although a similar effect
was also observed at different cranial levels (Fig. 2D,E).
Moreover, many of the additional HNK1-labelled cells were
located at more retarded positions along the migratory
pathway, and ectopic epithelial cells were also labelled by
HNK1 throughout the electroporated side of the
neuroepithelium (Fig. 2F-H). None of these effects was
observed when pCX-EGFP alone was electroporated (not
shown).
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Fig. 1. Expression patterns of LSox5 in the cephalic
region of chick embryos. Dorsal views of stage 7 (A),
8 (D), 9 (F) and 10 (G) embryos show the expression
of LSox5 mRNA in the neural folds/neural tube,
following a pattern compatible with premigratory and
migratory cephalic neural crest. Transverse sections
of stage7 (B,C) and stage 10 (H,I) embryos show
LSox5 expression all along the dorsoventral axis of
the neural tube at prosencephalic levels (B,H), and a
restriction to the most dorsal region at more caudal
levels (C,I). (E) A dorsal view of a stage 8 embryo
showing the expression of Slug in territories
competent to form neural crest, and its absence from
the non-crest producing prosencephalic regions.
(J-L) A transverse section of a stage 10 embryo at the
hindbrain level labelled with both anti-LSox5 (green)
and anti-Slug (red) antibodies. Only a subpopulation
of the cells within the neural tube (nt) express both
Slug and LSox5, whereas all the migratory cells
express both genes. LSox5 expression increases along
the cell migratory tracts, while Slug expression
diminishes in some migratory cells. (M) A transverse
section of a stage 10 embryo at the level of the rostral
hindbrain shows that as migration proceeds, LSox5
immunoreactive cells (green) acquire the HNK1
epitope (red). (N) Parasagittal section of a stage 25
embryo showing the proximal segment of the
oculomotor nerve. LSox5 expression (green) is high
in the precursors of the Schwann cells, where it
coincides with the P0 marker. (O) Section through the
ophthalmic lobule of the trigeminal ganglion of an
E5.5 (stage 28) embryo double stained for Islet (red)
and LSox5 (green). The small nuclei,
morphologically associated with satellite glia, express
LSox5, while those of the neuroblasts express Islet.
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The additional population of migratory cells were very
probably bona fide neural crest cells, as they also expressed
premigratory neural crest markers. Indeed, we found a
dramatic increase in the number of Pax7-, RhoB- and Slug-
expressing cells on the electroporated side of the dorsal neural
tube (Fig. 2I-K, L and M, respectively). In addition to
neuroepithelial cells in the dorsal neural tube, Pax7 is also
expressed in a population of cranial neural crest migrating from
the mesencephalon and rhombomeres 1, 3 and 5 (Kawakami
et al., 1997). Coincidently, N-cadherin, the expression of which
disappears in delaminating crest cells (Nakagawa and Takeichi,
1995), was also diminished in this region (Fig. 2N). Finally,
the basement membrane was disrupted, indicating that these
crest cells could undergo the epithelial-mesenchyme transition
and delaminate (Fig. 2K,L). The misexpression of LSox5 also
generated some scattered RhoB-expressing cells at more
ventral locations within the electroporated tube, and some of
these cells appeared to delaminate from this ectopic site (Fig.
2O). However, ectopic expression of Slug was never detected
at intermediate or ventral regions of the tube (Fig. 2M). In
summary, ectopic overexpression of LSox5 in the neural tube
upregulated Pax7, Slug and RhoB expression dorsally,
expanding the delaminating domain and increasing the
migratory neural crest population. More ventrally, some
ectopic RhoB-positive cells were generated that did not express
Slug, although some of them seemed capable of exiting the
neural tube.
The induction of RhoB is an immediate response to
LSox5 misexpression
Under normal conditions, the onset of Slug expression occurs
before that of LSox5. Considering that the onset of LSox5 and
RhoB expression occurs within a similar timescale, and that
LSox5 is able to induce RhoB in areas where Slug was not
induced (Fig. 2O), we examined whether LSox5 could induce
RhoB within short periods of time and whether this was
independent of Slug induction. On the transformed side of the
neural tube, we could identify a number of cells that expressed
EGFP and LSox5 6-7 hours after electroporation (Fig. 3A,B).
In these embryos, ectopic RhoB expression was also detected
in the intermediate and ventral regions of the neural tube (Fig.
3C), but no abnormal Slug expression could be observed (not
shown). Moreover, no ectopic cells expressing RhoB were
observed in the contralateral side of the tube or in control
embryos electroporated with pCX-EGFP alone (not shown).
The rapid appearance of ectopic cells expressing both LSox5
and RhoB suggested that the forced expression of LSox5
directly induced RhoB expression in the neural tube (Fig. 3D-
Fig. 2. LSox5 misexpression in the cephalic
neural tube augments the neural crest
population. (A) Dorsal view of an embryo 20
hours after co-electroporation with pCX-
LSox5 and PCX-EGFP on the right-hand side
of the cephalic neural tube. The EGFP
expression is seen on the treated side and in
the emerging streams of migratory neural
crest cells (white arrowheads).
(B,C) Transverse sections of an electroporated
embryo showing the coincident expression of
EGFP and ectopic LSox5 all along the
dorsoventral axis of the right hand side of the
neural tube. (D,E) Lateral views of an
electroporated embryo immunostained for
HNK1 where the increase in HNK1-positive
migratory cells in the electroporated (ep) side
can be observed, particularly in the
circumpharyngeal stream (black arrowhead).
(F,G) A transverse section at the level of the
caudal hindbrain shows the supernumerary
HNK1-positive migratory cells (red) in the
electroporated side of the embryo. (H) A
magnification of G shows the appearance of
ectopic HNK1-positive cells within the
treated side of the neural tube (arrowheads).
(I,J) At the hindbrain level, in a double
immunostained transverse section, the
overexpression of Pax7 (red) in cells
expressing EGFP (green) can be seen in both
neuroepithelial and migratory cells on the
LSox5 transfected side. (K,L) An overlay of
RhoB hybridisation and double immunostaining for Pax7 (green) and laminin 1 (red) shows that severe damage of the basement membrane
coincides with the expanded region of neural crest delamination on the electroporated side of the neural tube. (M,N) Transverse sections of
electroporated embryos hybridised for LSox5 and Slug (M), and N-cadherin (N). The territory competent for neural crest generation extends
ventrally on the electroporated side, as judged by the expanded expression of Slug (M) and the coincident inhibition of N-cadherin expression
(compare the length of the brackets on both sides of the neural tube). (O) At more ventral regions of the neural tube, scattered cells could be
detected that ectopically expressed RhoB on the treated side of the neural tube, breaking the basal lamina and invading into the lateral
mesenchyme (open arrowhead). ov, otic vesicle.
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F). Interestingly, this induction was transitory in intermediate
and ventral regions of the neural tube because 12 hours after
electroporation only a fraction of the EGFP-labelled cells here
expressed RhoB. Similarly, after 20 hours, the dorsal domain
of RhoB expression had expanded and a few scattered ectopic
RhoB-expressing cells were detected out of this region.
LSox5 misexpression upregulates the expression of
FoxD3 and Sox10
The transcription factors Sox10 and FoxD3 have both been
implicated in the generation of the neural crest and in the
posterior selection of crest-derived non-neural phenotypes
(Aoki et al., 2003; Britsch et al., 2001; Dottori et al., 2001; Kos
et al., 2001). Given the expression pattern of LSox5 in the
peripheral glia, we examined whether LSox5 misexpression
influenced either Sox10 or FoxD3 activity. The expression
pattern of these two factors did not appear to have been altered
by the misexpression of LSox5 within 6-7 hours of
electroporation (data not shown). However, 12 hours after
electroporation, the number of cells expressing both Sox10 and
FoxD3 increased on the electroporated side of the embryo (Fig.
4A-D). Under these conditions, the embryos had developed to
stage 11-11+ when the generation of the neural crest at
mesencephalic and rostral hindbrain levels has normally
terminated, and the neural crest cells are already at a distance
from the dorsal neural tube. Indeed, this distancing of the
neural crest population was apparent on the control side of the
embryos. By contrast, cells continued to delaminate, and
Sox10- and FoxD3-expressing cells were still detected in the
neural tube on the electroporated side (Fig. 4B,D). This result
indicates that the capacity to produce neural crest cells was
temporally extended following LSox5 misexpression.
Similar, yet more dramatic, phenotypes were observed 20-
24 hours after electroporation, when the embryos had reached
stages 13-14 (Fig. 4E-K). In these embryos, retarded migratory
cells expressing Sox10 and FoxD3 were found in the midbrain
and rostral hindbrain, where neural crest production normally
ceases around stage 11 (Fig. 4E,G,K). In more caudal regions,
Sox10 and FoxD3 expression was significantly augmented in
the different migratory streams of crest cells, particularly in the
circumpharyngeal crest (Fig. 4H-K). Cells exiting the neural
tube at aberrant, more ventral locations were also observed in
these embryos (Fig. 4L,M). Moreover, as for Slug, the ectopic
cells expressing LSox5 did not express Sox10 or FoxD3 (Fig.
4L,M).
LSox5 misexpression drives neural crest
differentiation towards non-neuronal phenotypes
The persistence of LSox5 in the cephalic neural crest derived
glial lineage, and the increased expression of both Sox10 and
FoxD3 upon LSox5 misexpression, prompted us to analyse the
fate of electroporated cells. In embryos that were allowed to
develop for 48 hours after LSox5 electroporation, many EGFP-
labelled cells reached the branchial arches or were spread
across the most rostral mesenchyme (not shown). Thus, it
seemed likely that these cells might be related to the non-neural
crest derivatives. In the cranial ganglia, electroporated cells
were preferentially detected at sites where Schwann cell
precursors accumulate, both at the entrance and exit of the
corresponding cranial nerve (Fig. 5). We also found labelled
cells interspersed with neuronal precursors of placodal origin
at the distal region of the trigeminal ganglion (Fig. 5A,B), the
geniculate ganglion (Fig. 5C,D) and the petrosal ganglion (not
shown). By contrast, labelled cells were very rarely found in
the proximal region of the trigeminal ganglion where neural
crest-derived neuronal precursors accumulate. In the ciliary
and superior ganglia, the neuronal precursors are all of neural
crest origin, but they did not coincide with LSox5
overexpressing cells (Fig. 5E-H). These data suggest that
LSox5 overexpression in neural crest cells drives the
differentiation of non-neuronal phenotypes.
SSox5 behaves as LSox5 when misexpressed in the
neural tube
As well as LSox5, a shorter isoform is also generated from the
SOX5 genes, SSox5 (Fig. 6A), which contains only the HMG
box for DNA binding and a unique coiled-coil domain (Denny
et al., 1992; Wunderle et al., 1996). Although SSox5 is
expressed in adult testis in the mouse (Hiraoka et al., 1998), it
was not detected in embryonic chick extracts. However, as a
first approach to analyse the functional domains responsible for
the activity of LSox5, we analysed the effects of expressing the
putative chick orthologue of mammalian SSox5 in the neural
tube. With respect to the expression of RhoB, Sox10 and FoxD3
after electroporation, this short form behaved very similarly to
the long isoform (Fig. 6B,C). These results indicate that the
structural information contained in SSox5 is sufficient to
Development 131 (18) Research article
Fig. 3. Rapid activation of RhoB after ectopic LSox5 expression in
the cephalic neural tube. Expression of EGFP (A); LSox5 (B,E,F) or
RhoB (C,D,F) in embryos fixed 6-7 hours after electroporation with
pCX-LSox5. A few transformed cells ectopically expressing LSox5
can be detected scattered within the neural tube with the anti-LSox5
serum (A,B). In situ hybridisation for RhoB at a mesencephalic level
shows that the ectopic activation of this gene in cells at the
electroporated side is analogous to the expression of LSox5 (C). The
cells that ectopically express RhoB correspond to those with higher
levels of ectopic LSox5 expression in their nuclei (D-F).
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influence neural crest development in the manner that we have
observed with LSox5.
Discussion
Structural features of chicken LSox5
We have cloned the chicken orthologue of the Sox5 gene,
which appears to generate at least two long isoforms (LSox5-
I and -II) during early embryogenesis. Sox5 is a member of the
D subgroup of the Sox gene family (Schepers et al., 2002). A
short isoform of Sox5 (SSox5), containing an HMG DNA-
binding domain and a small coiled-coil region, was originally
described in adult mouse testis (Denny et al., 1992). Long
isoforms were later found in mammals (Hiraoka et al., 1998;
Lefebvre et al., 1998; Ikeda et al., 2002) that, like other
members of the D subgroup (Sox6, Sox13), contain an extra
coiled-coil domain and glutamine-rich stretches. In spite of the
tight regulation that restricts SSox5 expression to specific adult
tissues, we have shown that SSox5 is capable of producing the
effects characterised in this study. If LSox5 does not harbour
a transactivation domain, as suggested in some in vitro studies
(Lefebvre et al., 1998), the formation of heterodimers with
other transcription factors should be considered and the unique
Fig. 4. Ectopic LSox5 expression in the cephalic
neural tube upregulates the expression of specific
neural crest markers. Embryos were electroporated
with pCX-LSox5 on the right-hand side of the neural
tube, left to develop for 12 (A-D) or 20-24 hours (E-
M), and then subjected to in situ hybridisation to
visualise the expression of LSox5 and/or FoxD3 or
Sox10. (A,C) Dorsal view of the midbrain and anterior
hindbrain of two embryos showing an increase in
FoxD3- and Sox10-expressing cells on the transfected
side. Transverse sections of these embryos (B,D) show
the appearance of ectopic premigratory cells
expressing these markers. Dorsal (E) or lateral views
(F,G) of two treated embryos show the dramatic
increase in FoxD3 and Sox10 expression on the
transfected side (ep) 20-24 hours after electroporation.
The effect is particularly remarkable in transverse
sections at the level of the circumpharyngeal crest
(J,K). (H,I) Diagrams representing the area covered by
FoxD3- or Sox10-expressing cells in 40 m m serial
sections through the cephalic region of the same
embryos. These data enable us to estimate the number
of cells expressing these markers along the
anteroposterior axis (in arbitrary units). A larger area
of expression is associated with the transfected side
(red bars) in most sections. The red lines correspond to
the transverse section in B (A), D (C), J (E,H) and K
(F,G,I). (L-M) Transverse sections at a mesencephalic
level showing transformed neuroepithelial cells that
seem to leave the neural tube beyond the dorsal
competence domain (arrowheads) and do not express
FoxD3 or Sox10. ov, otic vesicle.
Fig. 5. Deviation of neural crest derivatives to the glial lineage.
Parasagittal sections of the head region of embryos 48 hours after
electroporation of LSox5 showing the formation of the trigeminal
(A,B), facial (C,D), ciliary (E,F), and superior (G,H) ganglia. Serial
sections immunostained for LSox5 (green in A,C,E,G) or EGFP
(green in B,D,F,H) show the distribution of transformed neural crest
cells that maintain LSox5 overexpression. The exposure time was
reduced in A,C,E,G to visualise only LSox5-overexpressing cells
with signals above the normal level in glial cells. These cells are
preferentially located at the proximal entrance of the corresponding
cranial nerve (yellow arrowheads) or at the distal exit point (white
arrowheads). Transformed cells are excluded from the proximal
region of the trigeminal ganglion (broken line in A,B), where neural
crest derived neurons should differentiate, and there is a consistent
failure to colocalise with the neuronal marker (Islet, in red).
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coiled-coil structure present in SSox5 may represent an
interactive domain.
Not only does the overall sequence of chick LSox5 show a
high degree of similarity to that of its mammalian orthologue
but the HMG box is identical. Nevertheless, one structural
feature that distinguishes chick LSox5 derives from the fact
that 16 out of the 33 amino acid substitutions between the
mouse and the predicted chicken protein lie within residues
426-456. Strikingly, nine of these changes imply the gain of
serine or threonine residues in the chick protein, including a
specific serine rich domain (SRD). Indeed, when scanned for
putative phosphorylation sites (Blom et al., 1999), they mainly
lie in this region of LSox5 and some of the substitutions in the
chick sequence generate new sites. This suggests that in the
chicken, specific mechanisms may exist to regulate LSox5
activity by phosphorylation. Indeed, the regulation of Sox
function by serine phosphorylation has been demonstrated:
LSox5, Sox6 and Sox9 cooperate in the transactivation of a
Col2a1 chondrocyte-specific enhancer during cartilage
formation, and the activity of Sox9 in this process is controlled
by cyclic AMP-dependent protein kinase A phosphorylation
(Huang et al., 2000).
LSox5 expression in the neural crest
We isolated chicken LSox5 while searching for genes that are
induced or upregulated between embryonic stages 8-11, a
period during which the cephalic neural crest forms and begins
to migrate. LSox5 satisfied the criteria of the screen because it
is expressed in the cephalic neural crest, both premigratory and
migratory. However, we also detected LSox5 expression in the
trunk neural crest, albeit at much lower levels (not shown). At
early developmental stages, LSox5 is observed in the neural
folds, but while it is expressed in the whole of the prospective
forebrain epithelium, in more caudal regions it is restricted to
the most dorsal part of the neural tube where the neural crest
form. When compared with other neural crest markers, this
expression pattern is unique to LSox5. The two genes Slug and
Sox9 are restricted to the dorsal region of the neural plate and
the onset of their expression coincides with the generation of
the neural crest. By contrast, FoxD3 is first expressed in the
most rostral region of the neural folds and only becomes
restricted to the territories where the neural crest forms prior
to delamination (Kos et al., 2002). Thus, the initial expression
of FoxD3 and the persistence of LSox5 in the anterior
prosencephalon are likely to be related to developmental
processes other than the generation of the neural crest.
In the head, the onset of LSox5 expression follows the well-
established anteroposterior developmental gradient in the
dorsal neural folds/tube, as do most other neural crest markers.
However, Sox9, Slug and FoxD3 all precede LSox5, which
approximately coincides with RhoB and precedes Sox10
expression. It is interesting to note that LSox5, as Slug, is
continuously expressed at low levels throughout rhombomere
(r) 3, while other markers such as Sox9, FoxD3, RhoB and
Sox10 are never expressed in this rhombomere (Liu and Jessell,
1998; Cheng et al., 2000; Kos et al., 2002) (S.P.-A., M.A.N.
and J.A.B., unpublished). Although we do not know the
functional significance of this at present, the absence of many
neural crest markers may be related to the fact that the neural
crest produced in r3 undergoes massive apoptosis (Graham et
al., 1993). Those crest cells that survive in r3 are deviated
rostrally or caudally to contribute to the major migratory
streams adjacent to r2 and r4 (Birgbauer et al., 1995). Thus,
based on their relative expression patterns, we would locate
LSox5 downstream of Sox9, Slug and FoxD3, and at the same
hierarchical level or slightly upstream of RhoB and Sox10.
Early upregulation of RhoB caused by LSox5
misexpression
Taking into account the gene hierarchy that emerged by
analysing the endogenous expression in the neural crest, the
upregulation of RhoB appears to be an immediate consequence
of LSox5 misexpression in the neural epithelium. This
upregulation is a cell-autonomous phenomenon and it initially
presents near complete penetrance, i.e. most transformed cells
become RhoB-positive regardless of their location in the
dorsoventral axis of the neural tube. With time, and in parallel
with the number of LSox5-expressing cells within the neural
epithelium, the number of RhoB-expressing cells increases
dramatically at the dorsal aspect of the neural tube,
concomitant with a massive delamination of cells expressing
different neural crest markers. By contrast, the number of
RhoB-expressing cells remains low at intermediate and ventral
positions, suggesting that these environments are hostile to its
induction. RhoB has been proposed to contribute to the
changes in cell shape and adhesion that occur during the
delamination of neural crest cells by regulating actin
polymerisation, the formation of focal adhesions and of stress
fibres (Liu and Jessell, 1998). Accordingly, it should be noted
that some of the cells that are induced to express RhoB but that
lie outside of the dorsal domain of neural crest competence,
remain in the neural tube and maintain an epithelial aspect.
Only a few cells located outside of, but close to, the domain of
competence for crest formation seem to be able to delaminate
and enter the adjacent mesenchyme. However, even when they
are able to delaminate, these cells do not express any neural
crest markers other than the ectopic LSox5. These results
indicate that LSox5 is likely to induce RhoB expression
directly. Moreover, although this makes the cells competent to
undergo changes in cell shape, it is not compatible with them
undergoing complete EMT and fully acquiring the neural crest
phenotype, unless they are located in the crest-competent
domain. We also describe the appearance of HNK1-positive
cells within the neural epithelium as a consequence of LSox5
misexpression, a phenotype similar to that described following
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Fig. 6. SSox5 mimics the effects of LSox5 in misexpression assays.
(A) Comparison of the LSox5-II and SSox5 polypeptides. HMG,
HMG binding domain; cc, potential coiled-coil domains. 
(B,C) Transverse sections at rostral hindbrain levels hybridised with
RhoB or FoxD3 12 hours after electroporation with pCX-SSox5. Both
the ectopic expression of RhoB and the upregulation of FoxD3
observed here are very similar to those produced after LSox5
misexpression (Figs 3-5).
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FoxD3 or Sox9 misexpression (Kos et al., 2002; Cheung and
Briscoe, 2003). Although we have not checked if this aberrant
HNK1 expression coincides with or follows RhoB ectopic
expression, it seems plausible that this phenomenon mimics the
normal development of migratory neural crest cells, which
acquire the HNK1 epitope after expressing LSox5 and RhoB.
In addition, although we do not know the molecular
mechanisms involved in this particular behaviour, they may
also operate under physiological conditions. Whereas
physiological expression of Slug, Sox9 and FoxD3 is restricted
to the neural crest competent region in the dorsal neural tube,
both RhoB- and HNK1-positive cells can be found at more
ventral locations later in development (S.P.-A., M.A.N. and
J.A.B., unpublished).
LSox5 misexpression increases neural crest
generation
We have shown that LSox5 misexpression in the
neuroepithelium produces a dramatic increase in the generation
of neural crest cells, which express several neural crest
markers, including Pax7, Slug, FoxD3, RhoB, Sox10 and
HNK1. Within the head region, this effect can be detected at
all levels of the AP axis. Quantitative variation was found
between embryos that might reflect the precise timing of the
electroporation and analysis, and the efficiency of transfection.
Under our standard electroporation conditions, the extension
of the ‘temporal window’ of neural crest generation was best
visualised in the mesencephalic and rostral hindbrain regions.
Other aspects such as the increase in the number of migratory
cells were more evident in the circumpharyngeal streams.
Whereas the induction of RhoB expression can be detected
soon after the appearance of LSox5, the other markers are only
induced after longer periods of time, suggesting that their
induction is indirect. Before delamination, the ectopic crest
cells are located within a crest competent domain as defined
by overexpressing Slug (del Barrio and Nieto, 2002). The
expansion of this presumptive neural crest territory is
paralleled by the extension of the region in which the basement
membrane disassembles, allowing the delamination of the
neural crest cells that follow the normal migratory pathways.
In addition, the ‘temporal window’ of neural crest generation
is also extended, as has been observed after the misexpression
of other neural crest markers, such as Noelin 1 (Barenbaum et
al., 2000), FoxD3 (Kos et al., 2001; Dottori et al., 2001), Slug
(del Barrio and Nieto, 2002), Sox10 (Aoki et al., 2003) and
Sox9 (Cheung and Briscoe, 2003). As a matter of fact, many
features related to the increase of neural crest production after
LSox5 overexpression are similar to those described in the
aforementioned studies. It is thought that neural crest
overproduction occurs at the expense of other CNS cell types
(Dottori et al., 2001; Cheung and Briscoe, 2003).
Consequently, the overproduction of neural crest cells
frequently appears to deplete the cells from the most dorsal
region of the neural tube, as evident morphologically following
LSox5 misexpression.
Regardless of the generalised phenotype of neural crest
overproduction reported here, it is of interest to place LSox5 in
the genetic cascade of neural crest development. The
endogenous expression patterns tentatively locate it
downstream of Sox9, Slug and FoxD3, implying it acts after
neural crest induction and the segregation of the crest from the
other neuroepithelial cells. The results obtained after LSox5
overexpression indicate that it lies upstream of RhoB and
Sox10, compatible with studies indicating that RhoB is
involved in the delamination process and Sox10 in the survival
and maintenance of the stem cell properties in the migratory
population (Paratore et al., 2001; Kim et al., 2003;
Mollaaghababa and Pavan, 2003). However, earlier markers
were also upregulated when LSox5 was ectopically expressed
in neural crest cells at more extended times, suggesting that a
feedback loop may be at work in vivo. A precedent comes from
in vitro studies of EMT induction where a balanced cross-
modulation of cell-cell adhesion molecules, cell-ECM
adhesion molecules and cytoskeletal molecules can trigger and
orchestrate EMT (Newgreen and Minichiello, 1995; Somasiri
et al., 2001). Moreover, in a quail neural epithelial cell system
in vitro, the pharmacological inhibition of protein kinase C
immediately affects the cytoskeleton, provoking
transformation into crest-like cells (Minichiello et al., 1999)
and the upregulation of Slug and of Sox10 expression (D. F.
Newgreen, personal communication). In addition, a non-
autonomous cell response may be induced by extracellular
molecules (membrane proteins, soluble factors or matrix
molecules). Indeed, many neural crest cells in the migratory
streams on the transfected side did not express the EGFP
marker, raising the possibility of secondary or indirect
induction.
With respect to signalling molecules, previous studies have
shown that signals emanating from the non-neural ectoderm
and paraxial mesoderm, such as the BMPs, WNTs and FGFs,
induce neural crest differentiation (Liem et al., 1995; Ikeya et
al., 1997; LaBonne and Bronner-Fraser, 1998). However, the
overproduction of neural crest caused by the misexpression of
both FoxD3 and Sox9 has been placed downstream of these
dorsalising pathways (Dottori et al., 2001; Cheung and
Briscoe, 2003). The same seems to hold true for LSox5
misexpression. We have verified that Bmp4, Bmp7 and Wnt1
expression remains unaltered in treated embryos, although it
was sometimes diminished as a consequence of the depletion
of neuroepithelial cells in the dorsal tube (S.P.-A., M.A.N. and
J.A.B., unpublished).
During chondrocyte differentiation, Sox9 is required for the
expression of LSox5 (Akiyama et al., 2002), which
subsequently interacts cooperatively with Sox6 and Sox9 to
activate the type II collagen gene and promote chondrogenesis
(Lefebvre et al., 1998). We have analysed chick Sox6
expression by in situ hybridisation, verifying that it is not
expressed in either the dorsal neural tube or in early migratory
crest (S.P.-A., M.A.N. and J.A.B., unpublished). In the dorsal
neural tube, Sox9 activates a pathway leading to neural crest
induction, in which Sox10 is later induced (Cheung and
Briscoe, 2003). Sox10 expression is then maintained in the
peripheral glial lineage (Britsch et al., 2001), where it regulates
the expression of P0 (Peirano et al., 2000). Thus, it is tempting
to speculate that in neural crest development a similar
interaction between SoxE and SoxD factors to that observed
during chondroblast differentiation occurs. In this case, LSox5
would be the downstream a member of the Sox E group, Sox9,
and would interact with Sox10, another E-group member
during the premigratory stages and/or later on during the
differentiation of the glial lineage. In addition, as our
misexpression experiments suggest LSox5 may lie upstream of
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Sox10, the expression of which is induced later to cooperate at
stages of differentiation. Alternatively, Sox10 expression could
be independent of LSox5, but may be upregulated or induced
after forced LSox5 expression, in which case it would enter in
the pathway of neural crest generation by mimicking the role
of Sox9.
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